PatientsLikeMe ™

MS
Skip over navigation
Join Now (It's free!)

Already a member? Log in

Share your real-world treatment experience
with patients just like you.
Select a community
MS
Find out more about the PatientsLikeMe
MS Community

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Brand Names: Glycolax, Miralax, Movicol
See also: Glycolax, Miralax, Movicol

What is Polyethylene Glycol? Polyethylene glycol (or "PEG") is an osmotive laxative used to treat constipation. It is available in various branded formulations such as Glycolax, Miralax, or Movicol. Read more...Click to read more below


Reasons Taken

47 patients in the community are taking or have taken Polyethylene Glycol.

Reason # Patients Percentage of patients
Bowel problems 27 57%
Constipation 13 27%
Other 6 12%

Dosages

Based on the patients currently taking Polyethylene Glycol.

Top 10 (Show all)

All (Show Top 10)

  0 mg day 0 g none 0 mg none 0 tbs. none 0 none 1 tbs. day 1 tps. day 3 tbs. day 10 g day 17 g day 20 mg day 100 g none 100 g day
  1 Number of Patients: 1 9 Number of Patients: 9 4 Number of Patients: 4 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1 9 Number of Patients: 9  

Duration

How long current patients have been taking Polyethylene Glycol or how long patients were taking Polyethylene Glycol before stopping.

Currently taking Polyethylene Glycol

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
4
4
9
8
6

Stopped taking Polyethylene Glycol

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
0
1
1
1
2
Why Patients Stopped Taking Polyethylene Glycol (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 2 33% Did not seem to work: 33%
Other 2 33% Other: 33%
Expense 1 17% Expense: 17%
Course of treatment ended 1 17% Course of treatment ended: 17%


Back to top